• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析表达TIGIT的CD3CD56NK细胞在控制HIV-1感染不同阶段的特征

Analysis of the Characteristics of TIGIT-Expressing CD3CD56NK Cells in Controlling Different Stages of HIV-1 Infection.

作者信息

Zhang Xin, Lu Xiaofan, Cheung Allen Ka Loon, Zhang Qiuyue, Liu Zhiying, Li Zhen, Yuan Lin, Wang Rui, Liu Yan, Tang Bin, Xia Huan, Wu Hao, Zhang Tong, Su Bin

机构信息

Department of Infectious Diseases and Medical Immunology, Beijing Youan Hospital, Capital Medical University, Beijing, China.

Beijing Key Laboratory for HIV/AIDS Research, Beijing, China.

出版信息

Front Immunol. 2021 Feb 26;12:602492. doi: 10.3389/fimmu.2021.602492. eCollection 2021.

DOI:10.3389/fimmu.2021.602492
PMID:33717085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7953050/
Abstract

TIGIT expression on natural killer (NK) cells is associated with dysfunction during chronic HIV infection, but the phenotype and biological functions of these cells in the context of acute HIV-1 infection remain poorly understood. Here, 19 acutely infected HIV-1 patients traced at first, third and twelfth month, and age-matched patients with chronic HIV-1 infection were enrolled to investigate the phenotype and functions of TIGIT expression on NK cells. We found that TIGIT-expressing NK cells did not increase in frequency in the first, third and twelfth month of infection until chronic HIV-1 infection lasted over 2 years. The number of TIGITNK cells in acute infection was positively associated with HIV-1 viral load ( = 0.53, = 0.0009). CD96 was significantly upregulated on NK cells after acute infection for 1 month and in chronic infection over 2 years, while CD226 was downregulated in chronic infection over 2 years. Further, at different stages of infection, CD96CD226 cells diminished among total NK cells, TIGITNK and TIGITNK cells, while CD96CD226 cells expanded. Reduced CD96CD226 cells and elevated CD96CD226 cells among NK cells especially TIGITNK cells, had opposite associations with viral load in the first month of infection, as well as CD4 T-cell counts in including the twelfth month and more than 2 years of chronic infection. In both HIV-1-infected individuals and healthy donors, TIGIT was predominantly expressed in NKG2ANKG2CNK cells, with a significantly higher proportion than in NKG2ANKG2CNK cells. Moreover, the frequencies of TIGITNK cells were positively associated with the frequencies of NKG2ANKG2CNK cells in acute infection ( = 0.62, < 0.0001), chronic infection ( = 0.37, = 0.023) and healthy donors ( = 0.36, = 0.020). Enhanced early activation and coexpression of CD38 and HLA-DR in TIGITNK cells were detected compared to TIGITNK cells, both of which were inversely associated with the decrease in CD4 T-cell counts in both acute and chronic HIV-1 infection. The ability of TIGITNK cells to produce TNF-α, IFN-γ and CD107a degranulation substance were consistently weaker than that of TIGITNK cells in both acute and chronic infection. Moreover, the functionalities of TIGITNK cells were lower than those of TIGITNK cells, except for TNF-αCD107aIFN-γNK cells. These findings highlight the phenotype and functional characteristics of TIGIT-expressing NK cells which have poor capabilities in inhibiting HIV-1 replication and maintaining CD4 T-cell counts.

摘要

自然杀伤(NK)细胞上TIGIT的表达与慢性HIV感染期间的功能障碍有关,但在急性HIV-1感染情况下这些细胞的表型和生物学功能仍知之甚少。在此,招募了19例在第1、3和12个月进行追踪的急性HIV-1感染患者以及年龄匹配的慢性HIV-1感染患者,以研究NK细胞上TIGIT表达的表型和功能。我们发现,在感染的第1、3和12个月,表达TIGIT的NK细胞频率并未增加,直到慢性HIV-1感染持续超过2年。急性感染中TIGIT⁺NK细胞的数量与HIV-1病毒载量呈正相关(r = 0.53,P = 0.0009)。急性感染1个月后以及慢性感染超过2年时,NK细胞上的CD96显著上调,而慢性感染超过2年时CD226下调。此外,在感染的不同阶段,CD96⁺CD226⁻细胞在总NK细胞、TIGIT⁺NK和TIGIT⁻NK细胞中减少,而CD96⁻CD226⁺细胞增多。NK细胞尤其是TIGIT⁺NK细胞中CD96⁺CD226⁻细胞减少和CD96⁻CD226⁺细胞增多,在感染的第1个月与病毒载量以及在包括第12个月和慢性感染超过2年时的CD4⁺T细胞计数呈相反关系。在HIV-1感染个体和健康供体中,TIGIT主要在NKG2A⁺NKG2C⁻NK细胞中表达,其比例显著高于NKG2A⁻NKG2C⁺NK细胞。此外,急性感染(r = 0.62,P < 0.0001)、慢性感染(r = 0.37,P = 0.023)和健康供体(r = 0.36,P = 0.020)中,TIGIT⁺NK细胞的频率与NKG2A⁺NKG2C⁻NK细胞的频率呈正相关。与TIGIT⁻NK细胞相比,检测到TIGIT⁺NK细胞中CD38和HLA-DR的早期激活和共表达增强,这两者在急性和慢性HIV-1感染中均与CD4⁺T细胞计数的减少呈负相关。在急性和慢性感染中,TIGIT⁺NK细胞产生TNF-α、IFN-γ和CD107a脱颗粒物质的能力始终弱于TIGIT⁻NK细胞。此外,除了TNF-α⁺CD107a⁺IFN-γ⁺NK细胞外,TIGIT⁺NK细胞的功能低于TIGIT⁻NK细胞。这些发现突出了表达TIGIT的NK细胞的表型和功能特征,其在抑制HIV-1复制和维持CD4⁺T细胞计数方面能力较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/f99bad5ffbaf/fimmu-12-602492-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/99d3b7ce7bfa/fimmu-12-602492-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/e433a05afa3b/fimmu-12-602492-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/80f4334b2812/fimmu-12-602492-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/a860d4a695dc/fimmu-12-602492-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/c187c5818de2/fimmu-12-602492-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/3f40a33fbf44/fimmu-12-602492-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/f99bad5ffbaf/fimmu-12-602492-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/99d3b7ce7bfa/fimmu-12-602492-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/e433a05afa3b/fimmu-12-602492-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/80f4334b2812/fimmu-12-602492-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/a860d4a695dc/fimmu-12-602492-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/c187c5818de2/fimmu-12-602492-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/3f40a33fbf44/fimmu-12-602492-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f35/7953050/f99bad5ffbaf/fimmu-12-602492-g0007.jpg

相似文献

1
Analysis of the Characteristics of TIGIT-Expressing CD3CD56NK Cells in Controlling Different Stages of HIV-1 Infection.分析表达TIGIT的CD3CD56NK细胞在控制HIV-1感染不同阶段的特征
Front Immunol. 2021 Feb 26;12:602492. doi: 10.3389/fimmu.2021.602492. eCollection 2021.
2
Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.表达抑制性受体 TIGIT 在 HIV 感染者中特异性地上调于具有 CD226 激活受体的 NK 细胞上。
Front Immunol. 2018 Oct 10;9:2341. doi: 10.3389/fimmu.2018.02341. eCollection 2018.
3
Immune Dysfunctions of CD56 NK Cells Are Associated With HIV-1 Disease Progression.CD56 NK 细胞免疫功能紊乱与 HIV-1 疾病进展相关。
Front Immunol. 2022 Jan 7;12:811091. doi: 10.3389/fimmu.2021.811091. eCollection 2021.
4
Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects.在 HIV-1 暴露但血清阴性的受试者中,对 Toll 样受体 3 激活反应呈现低激活特征的多功能自然杀伤细胞。
Sci Rep. 2017 Apr 3;7(1):524. doi: 10.1038/s41598-017-00637-3.
5
A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.无论NKG2A+自然杀伤(NK)细胞是否共表达KIR3DL1,相较于NKG2A- NK细胞,有更高比例的NKG2A+ NK细胞会对自体HIV感染的CD4细胞产生反应。
J Virol. 2015 Oct;89(19):9909-19. doi: 10.1128/JVI.01546-15. Epub 2015 Jul 22.
6
Changing roles of CD3 + CD8 low T cells in combating HIV-1 infection.CD3+CD8 低表达 T 细胞在抗击 HIV-1 感染中的作用变化。
Chin Med J (Engl). 2023 Feb 20;136(4):433-445. doi: 10.1097/CM9.0000000000002458.
7
Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.自然杀伤细胞有助于乙型肝炎 e 抗原阴性慢性乙型肝炎病毒感染进展过程中的肝损伤,并有助于病毒持续存在。
Clin Microbiol Infect. 2016 Aug;22(8):733.e9-733.e19. doi: 10.1016/j.cmi.2016.05.009. Epub 2016 May 18.
8
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.一种新型Toll样受体9激动剂MGN1703增强HIV-1转录以及自然杀伤细胞介导的对HIV-1感染的自体CD4+ T细胞的抑制作用。
J Virol. 2016 Apr 14;90(9):4441-4453. doi: 10.1128/JVI.00222-16. Print 2016 May.
9
TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.TIGIT在HIV-1感染后上调,并标志着自然杀伤细胞中一个高度功能性的适应性成熟亚群。
AIDS. 2020 May 1;34(6):801-813. doi: 10.1097/QAD.0000000000002488.
10
NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.未经治疗的HIV感染个体的CD8 T细胞上的NK相关受体:CD56表达缺陷
AIDS. 2002 Jan 25;16(2):197-200. doi: 10.1097/00002030-200201250-00008.

引用本文的文献

1
Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1.联合树突状细胞和抗TIGIT免疫疗法增强适应性自然杀伤细胞对抗HIV-1的能力。
EMBO Mol Med. 2025 Jun 5. doi: 10.1038/s44321-025-00255-x.
2
Clinical and experimental treatment of residual immune activation in people living with HIV.HIV感染者残留免疫激活的临床与实验性治疗
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf023.
3
Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential.抑制TIGIT对自然杀伤细胞(NK细胞)的作用可提高其细胞毒性及清除HIV储存库的潜力。

本文引用的文献

1
TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.TIGIT在HIV-1感染后上调,并标志着自然杀伤细胞中一个高度功能性的适应性成熟亚群。
AIDS. 2020 May 1;34(6):801-813. doi: 10.1097/QAD.0000000000002488.
2
NK Cell Dysfunction and Checkpoint Immunotherapy.自然杀伤细胞功能障碍与检查点免疫治疗。
Front Immunol. 2019 Aug 21;10:1999. doi: 10.3389/fimmu.2019.01999. eCollection 2019.
3
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
mBio. 2025 Mar 12;16(3):e0322624. doi: 10.1128/mbio.03226-24. Epub 2025 Feb 7.
4
Enhancement of Human Immunodeficiency Virus-Specific CD8 T Cell Responses with TIGIT Blockade Involves Trogocytosis.通过TIGIT阻断增强人类免疫缺陷病毒特异性CD8 T细胞反应涉及噬细胞作用。
Pathogens. 2024 Dec 23;13(12):1137. doi: 10.3390/pathogens13121137.
5
Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing.去岩藻糖基化的广泛中和抗体通过细胞介导的杀伤增强了对 HIV-1 感染细胞的清除。
Commun Biol. 2024 Aug 9;7(1):964. doi: 10.1038/s42003-024-06659-8.
6
Immune Checkpoint Molecules and Glucose Metabolism in HIV-Induced T Cell Exhaustion.HIV诱导的T细胞耗竭中的免疫检查点分子与葡萄糖代谢
Biomedicines. 2022 Nov 4;10(11):0. doi: 10.3390/biomedicines10112809.
7
Negative Regulation and Protective Function of Natural Killer Cells in HIV Infection: Two Sides of a Coin.自然杀伤细胞在HIV感染中的负调控及保护作用:硬币的两面
Front Immunol. 2022 Mar 7;13:842831. doi: 10.3389/fimmu.2022.842831. eCollection 2022.
8
Immune checkpoint blockade in HIV.HIV 的免疫检查点阻断。
EBioMedicine. 2022 Feb;76:103840. doi: 10.1016/j.ebiom.2022.103840. Epub 2022 Feb 2.
9
TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4 T cells.TIGIT阻断增强了自然杀伤细胞对自体HIV-1感染的CD4 T细胞的活性。
Clin Transl Immunology. 2021 Oct 19;10(10):e1348. doi: 10.1002/cti2.1348. eCollection 2021.
DNAX辅助分子-1与TIGIT/PVRIG/TACTILE轴:基于自然杀伤细胞的癌症免疫疗法的新型免疫检查点
Cancers (Basel). 2019 Jun 23;11(6):877. doi: 10.3390/cancers11060877.
4
Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer.TIGIT 在淋巴组织、炎症和癌症中的表达模式。
Dis Markers. 2019 Jan 10;2019:5160565. doi: 10.1155/2019/5160565. eCollection 2019.
5
Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth by Suppressing the Function of NK and CD8 T Cells.免疫检查点分子 TIGIT 的内在表达可能通过抑制 NK 和 CD8 T 细胞的功能来帮助肿瘤生长。
Front Immunol. 2018 Nov 29;9:2821. doi: 10.3389/fimmu.2018.02821. eCollection 2018.
6
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.人 CD96 与自然杀伤细胞耗竭相关,并可预测人肝细胞癌的预后。
Hepatology. 2019 Jul;70(1):168-183. doi: 10.1002/hep.30347. Epub 2019 Mar 5.
7
NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies.自然杀伤细胞在 HIV-1 感染中的作用:从基础科学到疫苗策略。
Front Immunol. 2018 Oct 17;9:2290. doi: 10.3389/fimmu.2018.02290. eCollection 2018.
8
Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.表达抑制性受体 TIGIT 在 HIV 感染者中特异性地上调于具有 CD226 激活受体的 NK 细胞上。
Front Immunol. 2018 Oct 10;9:2341. doi: 10.3389/fimmu.2018.02341. eCollection 2018.
9
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.针对免疫检查点受体和分子的自然杀伤细胞治疗调节。
Front Immunol. 2018 Sep 10;9:2041. doi: 10.3389/fimmu.2018.02041. eCollection 2018.
10
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.阻断检查点受体 TIGIT 可防止 NK 细胞耗竭并引发强大的抗肿瘤免疫。
Nat Immunol. 2018 Jul;19(7):723-732. doi: 10.1038/s41590-018-0132-0. Epub 2018 Jun 18.